MedPath

To compare the effect of esmolol v/s dexmedetomidine on blood pressure and heart rate during and after laryngoscopy and endotracheal intubation in patients undergoing elective laprascopic gynecological surgeries.

Not yet recruiting
Conditions
Inflammatory disease of cervix uteri, (2) ICD-10 Condition: R098||Other specified symptoms and signsinvolving the circulatory and respiratory systems,
Registration Number
CTRI/2022/10/046140
Lead Sponsor
Department of anaesthesiology Sawai mansingh medical college and attached hospitals
Brief Summary

The purpose of your study is to compare the effects of esmolol and dexmedetomidine on heart rate and blood pressure in response to laryngoscopy and endotracheal intubation and to find out which drug is more effective.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • 1.ASA grade 1-2.
  • 2.patients body weight 40-70 kgs.
  • 3.undergoing laparoscopic gyencological surgery.
Exclusion Criteria
  • 1.patients not willing to give consent.
  • 2.patients with anticipated difficult airway and laryngoscopy time more than 20 seconds.
  • Chronic disease -hypertension , diabetes,hepatic disease.
  • 4.patients on beta blockers.
  • 5.pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the difference in change in hemodynamic response from baseline after administrating esmolol and dexmedetomidine during laryngoscopy and endotracheal intubationAt 1 min 3 min 5 min 7 min 10 min and at 20 min
Secondary Outcome Measures
NameTimeMethod
To determine proportion of cases who developed the side effects after administrating drug1,3,5,7,10,30min

Trial Locations

Locations (1)

SMS medical college

🇮🇳

Jaipur, RAJASTHAN, India

SMS medical college
🇮🇳Jaipur, RAJASTHAN, India
Dr chandrasekhar Chatterjee
Principal investigator
9828088092
chatterjee.chandrashekhar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.